EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
06/10/2025
Back to search
Official data from USPTO
272BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
272BIO
ST13
US500000079314153Class
5, 40, 42
Filing
79314153
Registration
6886491
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
06/11/2025
Trademark type
Word
Nice classes
5, 40, 42
Filing date
04/13/2021
Registration date
11/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2022
Last transaction
06/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
24
Owner location
GB
Examiner
LAVACHE, LINDA
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
272BIO Limited
Representatives
Robert S. Broder Collard & Roe, P.C.
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Veterinary preparations for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; medical preparations for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; pharmaceutical preparations for veterinary and/or medical use for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; biological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; biotechnological preparations for veterinary and medical use for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals; medicinesantibody therapeutic preparations and veterinary vaccines for livestock; biotherapeutic medicines for the prevention and treatment of autoimmune diseasescentral nervous system diseasescancerhematologic diseasesmetabolic disordersendocrine diseasescardiovascular diseaseimmune system related diseases and disordersinfectious diseaseskidney diseasesliver diseasesgastrointestinal diseasesgenetic conditionsinflammatory diseasesophthalmological conditionsoncologic disordersskin diseases and disordersrespiratory diseasesallergic diseasesneurological disorderspainpsychiatric disorder in livestock and other animals
Class 40
Custom manufacture of veterinary preparations and medical preparations; custom manufacture of pharmaceutical preparations for veterinary and medical use; custom manufacture of biological preparations for veterinary and medical use; custom manufacture of biotechnological preparations for veterinary and medical use; custom manufacture of medicines including biotherapeutic medicines
Class 42
Scientific research and development; biotechnological research and development; biotechnological research and development relating to animals and livestock; biotherapeutic product development; medical and veterinary laboratory services; clinical research in the field of veterinary preparationsbiotherapeutic medicinesantibodies; conducting clinical trials for others; informationadvice and consultancy relating to the aforesaid services
Publications
History of USPTO decisions and trademark events.
37 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/10/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/08/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/14/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2023
FIMP
FINAL DISPOSITION PROCESSED
02/22/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/01/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
08/23/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/16/2022
PUBO
PUBLISHED FOR OPPOSITION
08/16/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/12/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/27/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/27/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/14/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/14/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/14/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/14/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/20/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2022
RFNT
REFUSAL PROCESSED BY IB
01/23/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/06/2022
RFRR
REFUSAL PROCESSED BY MPU
01/06/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/09/2021
CNRT
NON-FINAL ACTION WRITTEN
12/08/2021
DOCK
ASSIGNED TO EXAMINER
12/04/2021
MAFR
APPLICATION FILING RECEIPT MAILED
07/02/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/28/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/25/2021
Continuous trademark protection
Get notified about every new filing that threatens 272BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.